WaferGen Bio-systems Reports Results for Second Quarter 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
WaferGen Bio-systems (WGBS) Misses Q2 EPS by 2c, Lowers FY Revenue Guidance
August 5, 2015 5:34 PM EDTWaferGen Bio-systems (NASDAQ: WGBS) reported Q2 EPS of ($0.67), $0.02 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.1 million.
2015 Guidance
Based on current sales trends and expectations, WaferGen is revising full-year 2015 revenue guidance to $7.5 million... More
